CLINIQUE MEDFUTURE RECEIVES AN INVESTMENT OF GNR REVOLUTION
Clinique Medfuture announces today that GNR Revolution is investing in the company to advance its strategic plan.
Mirabel, Quebec, Canada. -Clinique Medfuture confirms today that genetics Nanotechnology Robotics Revolution Inc., a private company, has completed its investment in the company.
Clinique Medfuture is positioned as a precursor in the field of longevity-oriented general services. In addition to home blood tests and private laboratory analyses, the company has recently launched new genetic testing in the Quebec market to assess the biological age and a shop designed to offer products from the latest Advances in the field of biotechnology in order to slow down ageing.
"Several experts are of the opinion that within 10 or 15 years we will add a year to our longevity every year we live, thus increasing our life expectancy further in the future." says Mario Tremblay, general manager of Clinique Medfuture. "Medfuture therefore wants to be a facilitator and an attendant for all those who want to take concrete steps to improve their chances of living longer in health"
The amount of the investment was not unveiled.
The company plans to expand its supply of services and products in the future through virtual medicine, regenerative medicine and anti-aging therapies.
About Clinique Medfuture Inc.
Clinique Medfuture's mission is to improve the longevity of their clients through the prevention, use of advanced technology and the practice of advanced medicine. The company currently offers at home or corporate blood collection service, more than 2000 laboratory tests and analyses with most of the results in 24h, whether routine testing or more specialized preventive genetic testing, with the addition of an online shop offering anti-aging products.